Presentation TCT 2020 Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease: The Disrupt CAD III Study Presenter: Dean J. Kereiakes October 15, 2020 REGISTER for free or LOG IN to view this content Coronary CAD Pharma Presentation TCT 2020 Disrupt CAD III Dean J. Kereiakes Up Next Presentation TCT 2020 The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients Presenter: Roxana Mehran October 15, 2020 More slides + Presentation TCT 2020 Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients Presenter: Michel Bosiers October 15, 2020 Presentation TCT 2020 Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation Presenter: Junjie Zhang October 15, 2020 We Recommend
Presentation TCT 2020 The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating the Safety of 3-month and 1-month DAPT in HBR Patients Presenter: Roxana Mehran October 15, 2020
Presentation TCT 2020 Featured Clinical Research: (TCT36010) MOTIV BTK Pilot Study – Initial Safety and Performance Study of the MOTIV Sirolimus-Eluting Bioresorbable Coronary Scaffold; Initial Report on First 10 Patients Presenter: Michel Bosiers October 15, 2020
Presentation TCT 2020 Three-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation Presenter: Junjie Zhang October 15, 2020